Sanara Medtech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -179.7% | – | – | – | -54.5% | -314.5% | – | -18.3% | +81.3% | -162.5% | – | – | |
| – | +9.7% | +1.0% | +8.9% | -8.3% | +45.7% | -30.1% | +5.6% | -48.6% | +4,096.3% | -97.7% | +5.4% | – | |
| – | +0.4% | -6.6% | +75.7% | -27.4% | +16.6% | +9.1% | +10.0% | -14.1% | -264.0% | – | +45.5% | – | |
| – | -218.8% | – | – | – | -81.3% | -797.3% | – | +74.1% | -321.4% | – | – | – | |
| – | -68.1% | +21.3% | -10.7% | -84.5% | +951.3% | +1,701.5% | +2.2% | -39.8% | -92.2% | -46.7% | -87.9% | – | |
| – | -99.5% | +21.3% | -10.7% | +10,718.3% | -98.0% | +3,884.7% | -24.2% | -12.9% | -28.5% | -98.2% | -87.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | -114.0% | -100.0% | – | – | – | – | |
| – | -102.0% | +254.4% | – | +201.1% | -108.3% | – | -120.6% | -68.6% | – | -440.8% | -56.6% | – | |
| – | -719.7% | – | – | +204.8% | -103.9% | – | -177.5% | – | – | -282.1% | – | – | |
| – | -201.0% | – | – | – | -59.0% | -544.9% | – | +23.7% | +245.8% | -165.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.